Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 72 results.
User Information
Export Records
  1. 1.   HIF1a Plays a Crucial Role in the Development of TFE3-Rearranged Renal Cell Carcinoma by Orchestrating a Metabolic Shift Toward Fatty Acid Synthesis
  2. Nishizawa, Hidekazu; Funasaki, Shintaro; Ma, Wenjuan; Kubota, Yoshiaki; Watanabe, Kazuhide; Arima, Yuichiro; Kuroda, Shoichiro; Ito, Takaaki; Furuya, Mitsuko; Motoshima, Takanobu; Nishiyama, Akira; Mehanna, Sally; Satou, Yorifumi; Hasumi, Hisashi; Jikuya, Ryosuke; Makiyama, Kazuhide; Tamura, Tomohiko; Oike, Yuichi; Tanaka, Yasuhito; Suda, Toshio; Schmidt,Laura; Linehan, W Marston; Baba, Masaya; Kamba, Tomomi
  3. Genes to Cells : devoted to molecular & cellular mechanisms. 2025, Jan; 30(1): e13195.
  1. 2.   IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma
  2. Bolomsky, Arnold; Ceribelli, Michele; Scheich, Sebastian; Rinaldi, Kristina; Huang, Da Wei; Chakraborty, Papiya; Pham, Lisette; Wright, George W; Hsiao, Tony; Morris, Vivian; Choi, Jaewoo; Phelan, James D; Holewinski,Ronald; Andresson,Thorkell; Wisniewski, Jan; Riley, Deanna; Pittaluga, Stefania; Hill, Elizabeth; Thomas, Craig J; Muppidi, Jagan; Young, Ryan M
  3. Cancer Cell. 2024, Jul 8; 42(7): 1185-1201.
  1. 3.   Transcription factor Tox2 is required for metabolic adaptation and tissue residency of ILC3 in the gut
  2. Das, Arundhoti; Martinez-Ruiz, Gustavo Ulises; Bouladoux, Nicolas; Stacy, Apollo; Moraly, Josquin; Vega-Sendino, Maria; Zhao, Yongge; Lavaert, Marieke; Ding, Yi; Morales-Sanchez, Abigail; Harly, Christelle; Seedhom, Mina O; Chari,Raj; Awasthi, Parirokh; Ikeuchi, Tomoko; Wang, Yueqiang; Zhu, Jinfang; Moutsopoulos, Niki M; Chen, WanJun; Yewdell, Jonathan W; Shapiro, Virginia Smith; Ruiz, Sergio; Taylor, Naomi; Belkaid, Yasmine; Bhandoola, Avinash
  3. Immunity. 2024, May 14; 57(5): 1019-1036.
  1. 4.   A Zpr1 co-chaperone mediates folding of eukaryotic translation elongation factor 1A via a GTPase cycle
  2. McQuown, Alexander J; Nelliat, Anjali R; Reif, Dvir; Sabbarini, Ibrahim M; Membreno, Britnie Santiago; Wu,Colin; Denic, Vladimir
  3. Molecular Cell. 2023, Aug 16; 81(17): 3108-3122.
  1. 5.   Hydropersulfides (RSSH) attenuate doxorubicin-induced cardiotoxicity while boosting its anticancer action
  2. Pharoah, Blaze M; Zhang, Chengximeng; Khodade, Vinayak S; Keceli, Gizem; McGinity,Chris; Paolocci, Nazareno; Toscano, John P
  3. Redox Biology. 2023, Feb 04; 60: 102625.
  1. 6.   Bimodal Imaging of Mouse Peripheral Nerves with Chlorin Tracers
  2. Gonzales, Junior; Hernandez-Gil, Javier; Wilson, Thomas C.; Adilbay, Dauren; Cornejo, Mike; de Souza Franca, Paula Demetrio; Guru, Navjot; Schroeder,Christina; King, Glenn F.; Lewis, Jason S.; Reiner, Thomas
  3. Molecular Pharmaceutics. 2021, Mar 1; 18(3): 940-951.
  1. 7.   Vav1 is Essential for HIF-1a Activation via a Lysosomal VEGFR1-Mediated Degradation Mechanism in Endothelial Cells
  2. Hong,Jaewoo; Min,Yongfen; Wuest, Todd; Lin,Charles
  3. Cancers. 2020, JUN; 12(6): E1374.
  1. 8.   Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?
  2. Sissung, Tristan M; Barbier, Roberto H; Price, Douglas K; Plona,Teri; Pike,Kristen; Mellott,Stephanie; Baugher,Ryan; Whiteley,Gordon; Soppet,Daniel; Venzon, David; Berman, Arlene; Rajan, Arun; Giaccone, Giuseppe; Meltzer, Paul; Figg, William D
  3. International journal of molecular sciences. 2020, Jan 30; 21(3): pii: ijms21030896.
  1. 9.   Targeting the Oncogenic Long Non-coding RNA SLNCR1 by Blocking Its Sequence-Specific Binding to the Androgen Receptor
  2. Schmidt, Karyn; Weidmann, Chase A; Hilimire, Thomas A; Yee, Elaine; Hatfield, Breanne M; Schneekloth,Jay; Weeks, Kevin M; Novina, Carl D
  3. Cell reports. 2020, Jan 14; 30(2): 541-554.e5.
  1. 10.   Does Ras Activate Raf and PI3K Allosterically?
  2. Nussinov,Ruth; Tsai,Chung-Jung; Jang,Hyunbum
  3. Frontiers in oncology. 2019, Nov 15; 9
  1. 11.   Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study
  2. Luo, Lei; An, Ping; Jia, Xinyong; Yue, Xiaobian; Zheng, Sujun; Liu, Shuang; Chen, Yu; An, Wei; Winkler, Cheryl; Duan, Zhongping
  3. Frontiers in genetics. 2018, Dec 18; 9: 662.
  1. 12.   Structural analyses of the Haemophilus influenzae peptidoglycan synthase activator LpoA suggest multiple conformations in solution
  2. Sathiyamoorthy, Karthik; Vijayalakshmi, J; Tirupati, Bhramara; Fan, Lixin; Saper, Mark A
  3. The Journal of Biological Chemistry. 2017, Oct 27; 292(43): 17626-17642.
  1. 13.   Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis
  2. Palmieri, Erika; Menga, Alessio; Martín-Pérez, Rosa; Quinto, Annamaria; Riera-Domingo, Carla; De Tullio, Giacoma; Hooper, Douglas C; Lamers, Wouter H; Ghesquière, Bart; McVicar, Daniel; Guarini, Attilio; Mazzone, Massimiliano; Castegna, Alessandra
  3. Cell Reports. 2017, Aug 15; 20(7): 1654-1666.
  1. 14.   Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor
  2. Xu, X.; Hou, Y.; Yin, X. Y.; Bao, L.; Tang, A. F.; Song, L. T.; Li, F. Q.; Tsang, S.; Wu, K.; Wu, H. J.; He, W. M.; Zeng, L.; Xing, M. J.; Wu, R. H.; Jiang, H.; Liu, X.; Cao, D. D.; Guo, G. W.; Hu, X. D.; Gui, Y. T.; Li, Z. S.; Xie, W. Y.; Sun, X. J.; Shi, M.; Cai, Z. M.; Wang, B.; Zhong, M. M.; Li, J. X.; Lu, Z. H.; Gu, N.; Zhang, X. Q.; Goodman, L.; Bolund, L.; Wang, J.; Yang, H. M.; Kristiansen, K.; Dean, M.; Li, Y. R.
  3. Cell. 2012, Mar; 148(5): 886-895.
  1. 15.   Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation
  2. Lee, M. H.; Lahusen, T.; Wang, R. H.; Xiao, C.; Xu, X.; Hwang, Y. S.; He, W. W.; Shi, Y.; Deng, C. X.
  3. Oncogene. 2012, Jan; 31(1): 116-127.
  1. 16.   Ablation of the transcriptional regulator Id1 enhances energy expenditure, increases insulin sensitivity, and protects against age and diet induced insulin resistance, and hepatosteatosis
  2. Satyanarayana, A.; Klarmann, K. D.; Gavrilova, O.; Keller, J. R.
  3. Faseb Journal. 2012, Jan; 26(1): 309-323.
  1. 17.   Population pharmacokinetic analysis of sorafenib in patients with solid tumours
  2. Jain, L.; Woo, S.; Gardner, E. R.; Dahut, W. L.; Kohn, E. C.; Kummar, S.; Mould, D. R.; Giaccone, G.; Yarchoan, R.; Venitz, J.; Figg, W. D.
  3. British Journal of Clinical Pharmacology. 2011, Aug; 72(2): 294-305.
  1. 18.   Nitric oxide donor, V-PROLI/NO, provides protection against arsenical induced toxicity in rat liver cells: Requirement for Cyp1a1
  2. Qu, W.; Cheng, L. D.; Dill, A. L.; Saavedra, J. E.; Hong, S. Y.; Keefer, L. K.; Waalkes, M. P.
  3. Chemico-Biological Interactions. 2011, Aug; 193(1): 88-96.
  1. 19.   Evolution of a Major Drug Metabolizing Enzyme Defect in the Domestic Cat and Other Felidae: Phylogenetic Timing and the Role of Hypercarnivory
  2. Shrestha, B. S. B.; Reed, J. M.; Starks, P. T.; Kaufman, G. E.; Goldstone, J. V.; Roelke, M. E.; O'Brien, S. J.; Koepfli, K. P.; Frank, L. G.; Court, M. H.
  3. Plos One. 2011, Mar; 6(3): 11.
  1. 20.   Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1 alpha Expression in an AhR-Independent Fashion
  2. Terzuoli, E.; Puppo, M.; Rapisarda, A.; Uranchimeg, B.; Cao, L. A.; Burger, A. M.; Ziche, M.; Melillo, G.
  3. Cancer Research. 2010, Sep 1; 70(17): 6837-6848.
  1. 21.   Structure of the Taz2 domain of p300: insights into ligand binding
  2. Miller, M.; Dauter, Z.; Cherry, S.; Tropea, J. E.; Wlodawer, A.
  3. Acta crystallographica. Section D, Biological crystallography. 2009, Dec; 65(Pt 12): 1301-8.
  1. 22.   Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans
  2. Meyer-Lindenberg, A.; Kolachana, B.; Gold, B.; Olsh, A.; Nicodemus, K. K.; Mattay, V.; Dean, M.; Weinberger, D. R.
  3. Molecular Psychiatry. 2009 14(10): 968-975.
  1. 23.   Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage
  2. Lo, P. H. Y.; Xie, D.; Chan, K. C.; Xu, F. P.; Kuzmin, I.; Lerman, M. I.; Law, S.; Chua, D.; Sham, J.; Lung, M. L.
  3. Cancer Letters. 2007, Nov; 257(2): 199-205.
  1. 24.   BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers
  2. Yuli, C.; Shao, N.; Rao, R.; Aysola, P.; Reddy, V.; Oprea-llies, G.; Lee, L.; Okoli, J.; Partridge, E.; Reddy, E. S. P.; Rao, V. N.
  3. Oncogene. 2007, Sep; 26(41): 6031-6037.
  1. 25.   A novel synthetic analogue of a constituent of Isodon excisus inhibits transcription of CYP1A1,-1A2 and-1B1 by preventing activation of the aryl hydrocarbon receptor
  2. Sienkiewicz, P.; Ciolino, H. P.; Leslie, B. J.; Hergenrother, P. J.; Singletary, K.; Yeh, G. C.
  3. Carcinogenesis. 2007, May; 28(5): 1052-1057.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel